Overview

The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
To compare the eradication success rate between 10-days sequential therapy and 7-days tailored therapy based on H. pylori culture and antimicrobial susceptibility testing.
Phase:
N/A
Details
Lead Sponsor:
Seoul National University Bundang Hospital
Treatments:
Amoxicillin
Anti-Infective Agents
Bismuth
Clarithromycin
Esomeprazole
Fluoroquinolones
Metronidazole
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Tetracycline